Algo version: 0.98b
MRSN is listed at the NASDAQ Exchange
MRSN [MRSN]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is MRSN stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Mersana Therapeutics Inc 10 years ago, but if you had invested on Wednesday 28th of June 2017 when the price was $14.00, you would have made a loss of $-12.64 per share or -90.29%

Yes, the average daily trading liquidity for Mersana Therapeutics Inc is $3.31 million. You should therefore be able to get in and out of your positions relatively fast.

Mersana Therapeutics Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Mersana Therapeutics Inc to be high [0.85 out of 1]